Abstract:

Endoscopic cyclophotocoagulation(ECP), as one of minimally invasive glaucoma surgery(MIGS), featured by observing the ciliary process directly and well controlling the laser energy and coagulation spots is regarded as a new option for the management of glaucoma. ECP has the advantages of controllable, less complications and better safety in treatment of refractory glaucoma, absolute glaucoma and congenital glaucoma. ECP combined phacoemulsification is now utilized in treatment of less advanced glaucoma coexisting with cataract in recent years with better outcomes including reduction of intraocular pressure and higher success rate. (Int Rev Ophthalmol,  2017,  41:    96-100)